Drug Profile


Alternative Names: NN 414

Latest Information Update: 02 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novo Nordisk
  • Class Antihyperglycaemics; Cyclic S oxides; Heterocyclic bicyclo compounds; Small molecules
  • Mechanism of Action Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 02 Feb 2017 Discontinued - Phase-II for Type-2 diabetes mellitus in Denmark (PO)
  • 06 Nov 2003 Suspended - Phase-II for Type-2 diabetes mellitus in Denmark (PO)
  • 16 Sep 2003 Data presented at the 18th International Diabetes Federation Congress (IDF-2003) have been added to the adverse events and Diabetes pharmacokinetics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top